PRESS RELEASE (February 19, 2019) —
Public Hearing Notice, February 19, 2019
The hearing can be watched here once it begins. More information about the hearing can be found here.
The Chairman wishes to inform Members that the Committee on Finance will meet on Tuesday, February 26, 2019, at 10:15AM, in 215 Dirksen Senate Office Building, to hear testimony on “Drug Pricing in America: A Prescription for Change, Part II.”
The following witnesses are scheduled to testify:
Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie Inc., North Chicago, IL
Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca, Wilmington, DE
Giovanni Caforio, M.D., Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb Co., New York, NY
Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals, Johnson & Johnson, New Brunswick, NJ
Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc., Kenilworth, NJ
Albert Bourla, DVM, Ph.D., Chief Executive Office, Pfizer, New York, NY
Olivier Brandicourt, M.D., Chief Executive Officer, Sanofi, Bridgewater, NJ
The Chairman urges every Member to attend.
